Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

The Frequency of BCR-ABL1 Fusion Transcripts in Iranian Patients with Three Different Types of Leukemia

Mohammad Hamid 1 , * and Hanieh Bokharaei 1
Authors Information
1 Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: July 2017, 19 (7); e10197
  • Published Online: July 31, 2017
  • Article Type: Research Article
  • Received: December 26, 2016
  • Revised: March 6, 2017
  • Accepted: May 8, 2017
  • DOI: 10.5812/zjrms.10197

To Cite: Hamid M, Bokharaei H. The Frequency of BCR-ABL1 Fusion Transcripts in Iranian Patients with Three Different Types of Leukemia, Zahedan J Res Med Sci. 2017 ; 19(7):e10197. doi: 10.5812/zjrms.10197.

Copyright © 2017, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Rostami G, Hamid M, Yaran M, Khani M, Karimipoor M. Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib. J Hum Genet. 2015; 60(5): 253-8[DOI][PubMed]
  • 2. Luatti S, Baldazzi C, Marzocchi G, Ameli G, Bochicchio MT, Soverini S, et al. Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy. Oncotarget. 2017; 8(18): 29906-13[DOI][PubMed]
  • 3. Sugapriya D, Preethi S, Shanthi P, Chandra N, Jeyaraman G, Sachdanandam P, et al. BCR-ABL Translocation in Pediatric Acute Lymphoblastic Leukemia in Southern India. Indian J Hematol Blood Transfus. 2012; 28(1): 37-41[DOI][PubMed]
  • 4. Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management. Am J Hematol. 2012; 87(11): 1037-45[DOI][PubMed]
  • 5. Osman EA, Hamad K, Elmula IM, Ibrahim ME. Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients. Genet Mol Biol. 2010; 33(2): 229-31[DOI][PubMed]
  • 6. Bjorkholm M, Ohm L, Eloranta S, Derolf A, Hultcrantz M, Sjoberg J, et al. Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol. 2011; 29(18): 2514-20[DOI][PubMed]
  • 7. Goh HG, Hwang JY, Kim SH, Lee YH, Kim YL, Kim DW. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR. Transl Res. 2006; 148(5): 249-56[DOI][PubMed]
  • 8. Yaghmaie M, Ghaffari SH, Ghavamzadeh A, Alimoghaddam K, Jahani M, Mousavi SA, et al. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia. Arch Iran Med. 2008; 11(3): 247-51[PubMed]
  • 9. Burmeister T, Reinhardt R. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts. Leuk Res. 2008; 32(4): 579-85[DOI][PubMed]
  • 10. Ferreira DC, de Oliveira JS, Parisio K, Ramalho FM. Pericardial effusion and cardiac tamponade: clinical manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Rev Bras Hematol Hemoter. 2014; 36(2): 159-61[DOI][PubMed]
  • 11. Burmeister T, Groger D, Kuhn A, Hoelzer D, Thiel E, Reinhardt R. Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias. DNA Repair (Amst). 2011; 10(11): 1131-7[DOI][PubMed]
  • 12. Bennour A, Ouahchi I, Achour B, Zaier M, Youssef YB, Khelif A, et al. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia. Med Oncol. 2013; 30(1): 348[DOI][PubMed]
  • 13. Park KJ, Woo YM, Kim K, Lee ST, Ki CS, Kim HJ, et al. Clinical application of catalytically cleavable fluorescence probe technology for multiplexing quantification of BCR-ABL1 fusion transcripts. Clin Chim Acta. 2013; [DOI][PubMed]
  • 14. Scrideli CA, de Oliveira FM, Brassesco MS, de Paula Queiroz R, Bernardes JE, Valera ET, et al. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood? Leuk Res. 2009; 33(3): 495-9[DOI][PubMed]
  • 15. Han JY, Theil KS. The Philadelphia chromosome as a secondary abnormality in inv(3)(q21q26) acute myeloid leukemia at diagnosis: confirmation of p190 BCR-ABL mRNA by real-time quantitative polymerase chain reaction. Cancer Genet Cytogenet. 2006; 165(1): 70-4[DOI][PubMed]
  • 16. Uchida N, Hanawa H, Dan K, Inokuchi K, Shimada T. Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector. J Nippon Med Sch. 2009; 76(3): 134-47[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments